Pectus Deformity, Pectus Excavatum
Conditions
Brief summary
In this randomized control trial, investigators would like to assess as primary objective the effectiveness of VR in anxiolysis via using State Trait Anxiety- Inventory test various time during the perioperative period with recorded physiologic data. As a secondary objective they are investigating the use of VR in the postoperative period for pain modulation via using pain numeric rating scales (NRS), monitoring physiologic data, and collecting information on painkiller demand of the patients.
Detailed description
This prospective, randomized controlled trial will be conducted with participants from the Paediatric Center, Semmelweis University, a tertiary level health care centre based in Budapest, Hungary. We evaluate the effects of VR immersion on reducing perioperative anxiety and postoperative pain. Participants will be asked to wear a VR headset for preferably an hour before and after the surgery. Patients will be asked to fill out three anxiety tests meanwhile investigators will record their vital parameters (HR, RR, SpO2, BP): on admission, in the operating room and on the surgical ward on the day after surgery. In the first postoperative day vital parameters, analgesic demand and NRS score will be recorded to follow patients pain status. Researchers will compare VR group to control group to see if anxiety and pain was different among those who recieved the VR headset.
Interventions
DEVICEVirtual reality exposure
Assessing immersive virtual reality as a distraction tool in anxiolysis and pain modulation.
Sponsors
Új Nemzeti Kiválóság Program
Semmelweis University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
* Patient between 13-18 years old * reported chest deformity (pectus excavatum/ carinatum) * patients undergoing MIRPE surgery in general anesthesia * Hungarian fluency * willing to comply with study procedures.
Exclusion criteria
* gross cognitive impairment that would interfere with the ability to consent or complete study procedures. * Head injury * Head infection * Altered mental status (independently from midazolam) * Scabies or louse * Dizziness or vertigo * Blindness or severe vision loss * Lack of parental/ guardian or patient consent * Those, who has a head deformity, so VR headset does not fit well
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in anxiety | 1-2 days | Anxiety assessed by STAI-S and STAI-T questionnaires level of anxiety will be assessed using the State Trait Anxiety-Inventory. The test is composed of 2 parts: STAI-S (How does the patient feel right now?) and STAI-T (How does the patient feel on average?). Both questionnaires contain 20 questions with answers rating from 1 to 4. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain and vital parameters | 1-2 days | Pain assessed by Numerical Pain Rating Scale level of pain will be assessed using the Numerical Pain Rating Scale. The scale is composed of 0 (no pain) to 10 (worst pain imaginable). Vital parameters that are monitored during the study are blood pressure, heart rate, peripheral oxygen saturation and respiratory rate. Pain will also be followed with analgesic demand per patien during the first postoperative day. |
Countries
Hungary
Outcome results
None listed